Efficacy News and Research

RSS
N439K mutation of SARS-CoV-2 may be more infectious and antibody resistant than Wuhan strain

N439K mutation of SARS-CoV-2 may be more infectious and antibody resistant than Wuhan strain

Combining cell engineering with machine learning to design living medicines for cancer

Combining cell engineering with machine learning to design living medicines for cancer

Transgenic mouse model could recapitulate severe COVID-19 in humans

Transgenic mouse model could recapitulate severe COVID-19 in humans

SARS-CoV-2 immunity can sustain for at least eight months, study finds

SARS-CoV-2 immunity can sustain for at least eight months, study finds

Novel CAR T-cell therapy shows promising early results in children with neuroblastoma

Novel CAR T-cell therapy shows promising early results in children with neuroblastoma

Inhibiting SARS-CoV-2 cell entry with monoclonal antibodies against staphylococcal enterotoxin B superantigen

Inhibiting SARS-CoV-2 cell entry with monoclonal antibodies against staphylococcal enterotoxin B superantigen

Iron infusion highly effective to treat anemia in low-income settings

Iron infusion highly effective to treat anemia in low-income settings

Convalescent plasma therapy ineffective in treating severe COVID-19, study finds

Convalescent plasma therapy ineffective in treating severe COVID-19, study finds

Researchers explore prevention measures for SARS-CoV-2 transmission during international travel

Researchers explore prevention measures for SARS-CoV-2 transmission during international travel

Dexamethasone use could reduce immune checkpoint inhibitor efficacy in glioblastoma patients

Dexamethasone use could reduce immune checkpoint inhibitor efficacy in glioblastoma patients

Robust antibody response to SARS-CoV-2 can persist for eight months, study finds

Robust antibody response to SARS-CoV-2 can persist for eight months, study finds

New drug lures stem cells to damaged tissue, improves treatment efficacy

New drug lures stem cells to damaged tissue, improves treatment efficacy

Researchers assess the unique advantages of bacteria in cancer treatment

Researchers assess the unique advantages of bacteria in cancer treatment

A review of Traditional Chinese herbal medicine in management of COVID-19

A review of Traditional Chinese herbal medicine in management of COVID-19

Mefloquine shows potential as anti-SARS-CoV-2 drug

Mefloquine shows potential as anti-SARS-CoV-2 drug

Inexpensive molecule shows potential to fight antibiotic-resistant bacteria causing gonorrhea, meningitis

Inexpensive molecule shows potential to fight antibiotic-resistant bacteria causing gonorrhea, meningitis

Protection of upper respiratory tract will require vaccines that mimic natural infection by SARS-CoV-2

Protection of upper respiratory tract will require vaccines that mimic natural infection by SARS-CoV-2

Study finds how the brain 're-wires' after neurological disease

Study finds how the brain 're-wires' after neurological disease

Largest clinical trial launched to treat mild-to-moderate COVID-19 patients in Africa

Largest clinical trial launched to treat mild-to-moderate COVID-19 patients in Africa

Potential treatment could reduce heart failure after a significant heart attack

Potential treatment could reduce heart failure after a significant heart attack

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.